Acne Vulgaris
📧 Sign up to get email alerts when something new happens for Acne Vulgaris.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2025-06-03FDA Approved: ISOTRETINOIN — Supplemental Application (Mayne Pharma)
FDA approved a supplemental application for isotretinoin submitted by Mayne Pharma.
-
CLINICAL_TRIALS research · 2025-05-30Clinical Trial Update: Emulsion 8-Week Anti-acne Efficacy Clinical Study [NA]
A clinical trial update for an 8-week anti-acne emulsion sponsored by ChinaNorm; the study is currently active but not recruiting. It includ…
-
CLINICAL_TRIALS research · 2025-05-28Clinical Trial Update: Role of Akkermansia Muciniphila in Acne Vulgaris [EARLY_Phase 1]
A Phase 1 early study at the Medical University of South Carolina is evaluating whether the gut bacterium Akkermansia muciniphila has a role…
-
FDA approval · 2025-05-22FDA Approved: ISOTRETINOIN — Original Application (Zydus Pharmaceuticals USA Inc.)
FDA approved the original application for a generic isotretinoin product from Zydus Pharmaceuticals USA Inc. This marks the approval of a ge…
-
CLINICAL_TRIALS research · 2025-05-18Clinical Trial Update: Clascoterone for Steroid-related Acne Vulgaris in Transgender Male Patients Receiving Masculinizing Hormone Therapy [Phase 1, Phase 2]
Ongoing Phase 1/2 clinical trials are evaluating clascoterone for steroid-related acne vulgaris in transgender men receiving masculinizing h…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-05-16Clinical Trial Update: Study to Evaluate the Safety and Efficacy of ASC40 in Subjects With Moderate to Severe Acne Vulgaris [Phase 2]
This document reports the completion of a Phase 2 clinical trial evaluating ASC40 for moderate to severe acne vulgaris.
-
CLINICAL_TRIALS research · 2025-05-14Clinical Trial Update: Dry Eye Disease With Isotretinoin ISOTRETINOIN
A Cairo University-sponsored clinical trial evaluating isotretinoin for acne vulgaris is currently not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2025-05-14Clinical Trial Update: Excimer Light Versus Blue Light in Acne [NA]
A clinical trial comparing excimer light to blue light for acne vulgaris is currently not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2025-05-13Clinical Trial Update: Efficacy and Tolerability of DispersinB Acne Cleanser in the Treatment of Mild to Moderate Acne Vulgaris [NA]
This clinical trial update reports on the efficacy and tolerability of DispersinB Acne Cleanser for mild-to-moderate acne vulgaris. The stud…
-
CLINICAL_TRIALS trial_result · 2025-05-07Clinical Trial Update: A Study Evaluating the Efficacy and Safety of Clascoterone Cream 1% in Skin of Color Patients With Acne [Phase 4]
A Phase 4 clinical trial evaluating clascoterone cream 1% for acne in skin of color patients has completed and posted results.
-
CLINICAL_TRIALS research · 2025-04-24Clinical Trial Update: Phenytoin in Treatment of Atrophic Post Acne Scars. [Phase 4]
Phase 4 trial from Assiut University evaluating phenytoin for treating atrophic post-acne scars; the study status is NOT_YET_RECRUITING.
-
FDA approval · 2025-04-22FDA Approved: RETIN-A MICRO — Supplemental Application (Bausch Health US LLC)
The FDA approved a supplemental application for RETIN-A MICRO (tretinoin) submitted by Bausch Health US LLC.
-
CLINICAL_TRIALS trial_result · 2025-04-20Clinical Trial Update: Study Evaluating the Efficacy and Safety of Omnilux Clear on Mitigating Mild to Moderate Acne [NA]
A completed clinical trial evaluating the efficacy and safety of Omnilux Clear LED light therapy for acne treatment.
-
FDA approval · 2025-04-17FDA Approved: CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for Clindamycin Phosphate and Benzoyl Peroxide from Actavis Pharma, Inc., for use in acne treatment.
-
CLINICAL_TRIALS trial_result · 2025-04-15Clinical Trial Update: A Study to Evaluate the Reduction in Sebum (Skin Oil) Induced by Clascoterone Cream 1% in Acne Patients [Phase 4]
A Phase 4 trial assessing whether clascoterone cream 1% reduces sebum production in patients with acne vulgaris; the study has completed.
-
CLINICAL_TRIALS research · 2025-04-13Clinical Trial Update: The Relationship Between Microbioma Balance and Acne Vulgaris as a New Acne Treatment [Phase 2]
Phase 2 clinical trial exploring a microbiome-based therapy for acne vulgaris, with status NOT_YET_RECRUITING.
-
CLINICAL_TRIALS trial_result · 2025-04-10Clinical Trial Update: Bio-equivalence Study With Clinical Endpoints in the Treatment of Acne Vulgaris [Phase 1]
A Phase 1 bio-equivalence study in acne vulgaris completed, assessing clinical endpoints between two formulations.
-
CLINICAL_TRIALS trial_result · 2025-04-06Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Clear Skin Formula on Mitigating Mild to Moderate Non-cystic Acne [NA]
This document reports the completion status of a clinical trial evaluating Clear Skin Formula for mild to moderate non-cystic acne and its s…
-
CLINICAL_TRIALS trial_result · 2025-04-04Clinical Trial Update: Study of New Antiandrogenic Progestogen + Low-dose Estrogen for Moderate Acne Vulgaris [Phase 3]
Phase 3 study evaluating a new antiandrogenic progestin combined with low-dose estrogen for moderate acne vulgaris. The trial is not yet rec…
-
FDA approval · 2025-03-31FDA Approved: DOXYCYCLINE — Supplemental Application (Par Health USA, LLC)
The FDA approved a supplemental application for doxycycline from Par Health USA, LLC under an ANDA, authorizing changes to the generic produ…
-
CLINICAL_TRIALS trial_result · 2025-03-30Clinical Trial Update: Phase II Trial of RA-18C3 in Subjects With Moderate to Severe Acne Vulgaris [Phase 2]
The update notes the completion of a Phase II trial of RA-18C3 in adults with moderate to severe acne vulgaris. The snippet does not provide…
-
CLINICAL_TRIALS research · 2025-03-25Clinical Trial Update: Clinical Trial to Compare Oral Isotretinoin to Standard of Care in Moderate Acne Skin of Color Patients [Phase 3]
A Phase 3 clinical trial is evaluating oral isotretinoin versus standard of care for moderate acne in skin of color patients, and is current…
-
FDA approval · 2025-03-17FDA Approved: AMNESTEEM — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for Amnesteem (isotretinoin) submitted by Mylan Pharmaceuticals. This represents an approved add…
-
CLINICAL_TRIALS trial_result · 2025-03-17Clinical Trial Update: Retinoic Acid Therapy and Regulation of Salivary and Serum IL-1β, IL-8 and MCP-1 Levels
A completed clinical trial evaluating retinoic acid therapy and its effect on salivary and serum inflammatory biomarkers IL-1β, IL-8, and MC…
-
CLINICAL_TRIALS trial_result · 2025-03-17Clinical Trial Update: A Post Market Device Study for the Treatment of Acne [NA]
This is a post-market device study by Cutera Inc. evaluating a treatment device for acne vulgaris. The study status is active but not recrui…